FREQUENCY AND ALLELE BURDEN OF CALR MUTATIONS IN CHINESE WITH ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS WITHOUT JAK2 V617F OR MPL MUTATIONS

被引：0
|
作者：
Li, N. [1 ,2 ]
Yao, Q. -M. [1 ,2 ]
Gale, R. P. [3 ]
Li, J. -L. [1 ,2 ]
Li, L. -D. [1 ,2 ]
Zhao, X. -S. [1 ,2 ]
Jiang, H. [1 ,2 ]
Jiang, Q. [1 ,2 ]
Jiang, B. [1 ,2 ]
Shi, H. -X. [1 ,2 ]
Chen, S. -S. [1 ,2 ]
Liu, K. -Y. [1 ,2 ]
Huang, X. -J. [1 ,2 ]
Ruan, G. -R. [1 ,2 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
[2] Inst Hematol, Beijing, Peoples R China
[3] Haematol Res Ctr, Div Expt Med, London, England
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1318
引用
收藏
页码：527 / 528
页数：2
相关论文
共 50 条
  • [31] WHOLE BLOOD PLATELET AGGREGATION IN PATIENTS WITH V617F JAK2 AND CALR MUTATIONS
    Gorbenko, A.
    Stolyar, M.
    Subbotina, T.
    Olkhovskiy, I.
    HAEMATOLOGICA, 2014, 99 : 663 - 663
  • [32] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [33] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
    Yang, Hai-Su
    CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
  • [34] IMPORTANCE OF JAK2 V617F ALLELE BURDEN IN THE DIAGNOSIS AND PHENOTYPIC MANIFESTATIONS OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Sanchez Diego, Martin
    Serna Raquel, Mata
    Gonzalez Daniel, Lainez
    Lopez Carlos, Blas
    Bonilla Tamara, Castano
    Sillero Pilar, Llamas
    Juan Manuel, Alonso Dominguez
    HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
  • [35] The JAK2 V617F mutational status and allele burden
    Liang, Shanshan
    Zhou, Yanhong
    THROMBOSIS RESEARCH, 2015, 136 (03) : 690 - 690
  • [36] A Case Report on Coexisting JAK2 V617F and Calr exon 9 Mutation in Essential Thrombocythemia
    Rashid, Munazza
    Ahmed, Rifat Zubair
    Ahmed, Shariq
    Nadeem, Muhammad
    Ahmed, Nuzhat
    Shamsi, Tahir
    BLOOD, 2015, 126 (23)
  • [37] Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
    Mónica Mejía-Ochoa
    Paola Andrea Acevedo Toro
    Jaiberth Antonio Cardona-Arias
    BMC Cancer, 19
  • [38] Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
    Zulkeflee, Razan Hayati
    Zulkafli, Zefarina
    Johan, Muhammad Farid
    Husin, Azlan
    Islam, Md Asiful
    Hassan, Rosline
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
  • [39] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
    Gango, Ambrus
    Mozes, Reka
    Boha, Zsofia
    Kajtar, Bela
    Timar, Botond
    Kiraly, Peter Attila
    Kiss, Richard
    Fesus, Viktoria
    Nagy, Noemi
    Demeter, Judit
    Korosmezey, Gabor
    Borbenyi, Zita
    Marton, Imelda
    Szoke, Anita
    Masszi, Tamas
    Farkas, Peter
    Varkonyi, Judit
    Plander, Mark
    Posfai, Eva
    Egyed, Miklos
    Pal, Katalin
    Radvanyi, Gaspar
    Hamed, Aryan
    Csomor, Judit
    Matolcsy, Andras
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
  • [40] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Tanja Belcic Mikic
    Tadej Pajic
    Matjaz Sever
    Scientific Reports, 9
12345